The most useful thing to know before starting immune-based treatment is that its side effects follow a different logic from chemotherapy. They are not caused by a toxic drug reaching healthy tissue. They are caused by an activated immune system turning towards healthy tissue, which means they can appear in almost any organ, can start late, and are managed by calming the immune response rather than waiting it out. This article sets out what is common, what is serious, and what should prompt a call the same day. How these treatments work is explained in what immunotherapy is and how it works.
Why Immunotherapy Side Effects Happen
Checkpoint inhibitors work by removing natural restraints on T cell activity. Those restraints exist for a reason: they prevent the immune system from attacking the body's own tissue. Releasing them raises activity against the intended target, and in some people also permits activity against healthy organs. Clinicians call the result immune-related adverse events.
Cell-based therapies can produce a different pattern, including reactions driven by a surge of inflammatory signalling shortly after infusion. This is why cell therapies with a high risk of that reaction are given in centres equipped to treat it immediately.
Immunotherapy Side Effects by Frequency
| Side effect | How often reported | Usual handling |
|---|---|---|
| Fatigue | Very common | Monitored, activity paced, other causes excluded |
| Rash and itch | Common | Topical treatment, dermatology review if widespread |
| Diarrhoea or colitis | Common, occasionally severe | Early reporting, steroids if inflammatory |
| Thyroid or hormone gland changes | Common | Blood monitoring, hormone replacement if needed |
| Joint and muscle aches | Common | Symptomatic care, review if persistent |
| Lung inflammation | Uncommon, potentially serious | Urgent imaging and treatment |
| Liver inflammation | Uncommon | Detected on routine bloods, treatment paused |
| Heart or kidney inflammation | Rare, serious | Immediate specialist assessment |
Frequency varies considerably between agents and between single-drug and combination regimens, and combinations generally carry a higher rate of significant reactions.
Serious Reactions and Warning Signs
- New breathlessness, a persistent dry cough or chest tightness
- Diarrhoea more than a few times a day, or any blood or mucus in the stool
- Yellowing of the eyes or skin, dark urine or pain under the right ribs
- Chest pain, palpitations, or swelling of the ankles
- Severe headache, visual change, or profound unexplained weakness
- Reduced urine output or rapid unexplained weight change
Any of these warrants contact with the treating team the same day. Delay matters with immune-related inflammation, because early treatment usually resolves what late treatment struggles with.
When Side Effects Appear and How Long They Last
Skin reactions tend to appear earliest, often within the first weeks. Bowel and liver effects commonly follow over the next one to three months. Hormone gland effects frequently appear later still and are often picked up on routine blood tests before the patient notices anything.
Duration varies by organ. Most inflammatory reactions settle over weeks with treatment. Damage to hormone glands, particularly the thyroid or pituitary, can be permanent, which means ongoing replacement therapy rather than recovery. That is usually straightforward to manage but needs to be explained clearly in advance.
How Side Effects Are Monitored and Managed
Monitoring is systematic rather than reactive. Blood tests before each cycle cover liver function, kidney function, thyroid and glucose. Symptoms are reviewed at every visit using standard grading, because the grade determines the response: continue and observe, pause, add steroids, or stop permanently.
Steroids are the first line for most significant immune-related reactions, with additional immune-suppressing medication used when the response is inadequate. Patients are usually given a card or letter identifying the treatment received, which should be shown to any clinician seen afterwards, including in an emergency department.
Monitoring at Our Bangkok Facility
At MRC Healthcare, any immune-based programme is run with defined monitoring written into the plan before the first session: which blood tests, at what intervals, and which findings pause treatment. Infusions are given under nursing observation with a physician available, and observation time after an infusion is set by the therapy rather than by the schedule.
Where supportive cell-based options such as NK cell therapy are part of a plan, their monitoring requirements are explained alongside those of the oncology treatment you are already receiving, and results are documented for your specialist at home.
Travelling Home After Immune-Based Treatment
- Agree an observation period before flying, and book flights around it
- Carry written documentation of exactly what was given and when
- Know which symptoms mean going to a hospital rather than waiting
- Arrange follow-up blood tests at home before you leave Bangkok
- Make sure your specialist at home has the full record
Patients travelling from Australia, Singapore, the United Kingdom and Europe should treat the weeks after treatment as part of the programme, not the end of it. Our Thailand medical travel checklist covers the documentation and timing side.
Related reading: conditions treated with immunotherapy and immunotherapy vs chemotherapy.
Ask About Monitoring Before You Start
Our medical team will explain exactly what is monitored, how often, and what happens if a reaction develops, before anything is agreed.
Schedule a Consultation
